Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 September 2021: Clinical Research

Prospective Study on the Postoperative Use of Levosimendan After Conventional Heart Valve Replacement

Wei Sheng ABCDEF* , Hui Qiao ABCDEF* , Zhaozhuo Niu BCE , Tianyi Wang BCE , Haoyou Li CDE , Wenfeng Zhang CDE , Jiantao Wu CDE , Xiao Lv ADEF*

DOI: 10.12659/MSM.932001

Med Sci Monit 2021; 27:e932001

Table 3 Comparison of other perioperative parameters between the 2 groups.

ParameterLevosimendan (n=93)Control (n=92)χ2 or t valueP value
Average dosage of dopamine after surgery (mg/Kg, mean±SD)11.5±1.820.4±2.130.9600.000
Administration time of dopamine after surgery (h, mean±SD)70.4±11.2110.5±12.123.3960.000
Duration of mechanical ventilation (h, mean±SD)13.5±3.614.2±4.21.2180.225
ICU length of stay (h, mean±SD)24.6±4.332.5±4.612.0680.000
Perioperative adverse events9259.4380.002
 Low cardiac output055.1950.023
 Renal insufficiency174.7720.029
 Perioperative myocardial infarction005.2830.022
 New atrial fibrillation6160.3500.554
 Malignant arrhythmia00
 Re-exploration12
ICU – Intensive Care Unit.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750